Axios Live: Virginia looks to schools amid weak funding to sustain biotech growth
Axios · Claire Moberg ·
Virginia's biotech growth is drawing schools, industry groups and local governments into a statewide effort to boost the industry's place in the region's economy, state and business leaders said at an Axios event.
RICHMOND — Virginia's biotech growth is drawing schools, industry groups and local governments into a statewide effort to boost the industry's place in the region's economy, state and business leaders said at an Axios event.
Why it matters: Education and workforce development efforts are investing in the biopharma talent pipeline earlier, even at the elementary school level, with the potential to connect more Virginians with jobs in the growing sector.
Axios' Sabrina Moreno and Brock Turner spoke to Virginia deputy secretary for commerce and trade Kristen Dahlman, Virginia Economic Development Partnership chief of talent and workforce strategy Megan Healy, Virginia Bio CEO John Newby and Goochland County administrator Jeremy Raley. The Oct. 29 event was sponsored by PhRMA.